Eli Lilly’s weight loss drug retatrutide helped nearly half of participants in a phase 3 trial to lose more than 30% of their weight after two years.
Live Above The Madness
MMN Editor Filed Under: Uncategorized
Eli Lilly’s weight loss drug retatrutide helped nearly half of participants in a phase 3 trial to lose more than 30% of their weight after two years.
Live market context: Watch the bigger money signal while tracking headlines, gold, oil, risk, and opportunity.
Fear, inflation, currency pressure, central banks, and global instability.
Energy pressure, shipping lanes, geopolitics, inflation, and consumer prices.
Follow shipping disruptions, war risk, inflation pressure, credit stress, dollar strength, and market instability.